Dedicated multidisciplinary scientific team
Expertise spanning biology
EASENG HOLDINGS
AI-driven development ofinnovative cell and gene therapies
Focused on therapeutic vaccines for hard-to-treat solid tumors and exosome-based therapeutics, supported by a proprietary bioinformatics platform, immune-cell drug development and exosome R&D platforms.
Our Mission
We focus on diseases with significant unmet medical needs, leveraging artificial intelligence to accelerate innovative drug discovery and development. Through our advanced platforms in therapeutic cancer vaccines and exosome-based therapeutics, we aim to address key scientific challenges and develop new treatment options for patients.
Our Core Strengths
Capabilities spanning research and translation
Proprietary algorithms
In-house multi-omics analysis and AI-powered neoantigen screening and validation capabilities.
Advanced cell manufacturing
Advanced processes for generating highly functional dendritic cells and developing exosome-based therapeutics.